Udhayvir Grewal, Resident Physician at Ochsner LSU Health Shreveport, shared on X:
“Grateful to the Nichole Borchard Foundation and NANETS for this incredible opportunity to develop a biomarker for DLL3-targeting therapies in high grade neuroendocrine neoplasms.
I’m eternally thankful to Jacob Berchuck for being a tireless mentor and collaborator (this is my second grant with him as a mentor).
Just the beginning! Can’t wait to do good science with this project.”
You can also read:
Laura Alder: Tarlatamab Demonstrates Strong Responses in DLL3-High Pulmonary Carcinoid
